Studies

Clinical Trials

Klinische Studien am IDF
StudyInclusion criteriaGoal of the studyContactInformation
Freder1k
  • newborns and babys till the age of 4 months of life in Bavaria, Lower Saxony, Saxony and Thuringia
costless early detection of type 1 diabetes risk in order to avoid complications and possibly to prevent type 1 diabetes

Dr. Christiane Winkler

tel.:
0800-000 00 18
(costless hotline)

Freder1k-Flyer

Website

Fr1daplus
  • all Bavarian children aged 2 to 5 and 9 to 10 years of life
early diagnosis of type 1 diabetes

Univ.-Prof. Dr. med. Anette-Gabriele Ziegler

tel.: 0800–4648835 (costless hotline)

Fr1daplus-Studie  - Infoflyer

Website

Fr1da Insulin Intervention
  • children aged between 2 und 12 years of life
  • with at least 2 islet autoantibodies (pre-type 1 diabetes)
  • with normal blood values in OGTT
  • resident all over Germany
The study examines whether type 1 diabetes at children with pre-type 1 diabetes could be prevented or delayed by application of oral insulin. 

Univ.-Prof. Dr. med. Anette-Gabriele Ziegler

tel.: 0800–4648835 (costless hotline)

Fr1da-Insulin-Interventions-Studie

Website

 

 

PINIT (screening and recruitment completed)
  • children aged between 1 and 7 years
  • with genetic risk for type 1 diabetes
  • without diabetes specific autoantibodies

therapy with nasal insulin to prevent type 1 diabetes

PD Dr. med. Peter Achenbach

tel. 0800-8284868
(costless hotline)

PINIT-flyer
POInT
  • children aged between 4 and 7 months of life
  • with genetic risk for type 1 diabetes
  • after beginning of complementary food
training of immune system by oral insulin in order to prevent destruction of insulin producing beta cells of the pancreas and to prevent pathogenesis of type 1 diabetes

Univ.-Prof. Dr. med. Anette-Gabriele Ziegler

PD Dr. med. Peter Achenbach

 

POInT-flyer

Website